OTC
GPs urge more patient ‘self care’ for minor ailments
September 30, 2010Medical Communications Doctors.net.uk, OTC, doctors, pharma, simon grime
Research by Doctors.net.uk, on behalf of OTC Bulletin, has revealed that nine out of ten general practitioners in the UK …
Sanofi bags consumer healthcare specialist Chattem
January 5, 2010Chattem, OTC, Sanofi
Sanofi-Aventis looks set to become much bigger in over-the-counter pharmaceuticals with a $1.9 billion agreement to buy US company Chattem. …
Bayer to launch OTC omeprazole in Germany
July 17, 2009Sales and Marketing Bayer, OTC
Bayer Vital, the marketing arm of Bayer HealthCare, is to launch the proton pump inhibitor omeprazole as an over-the-counter heartburn …
Doctors doubt benefits of OTC switches
January 15, 2009Sales and Marketing OTC
A survey of doctors has found many doubt that patients benefit from more prescription-only drugs being made available over-the-counter. Some …
Boehringer to switch Flomax from POM to P
December 3, 2008Sales and Marketing OTC
Boehringer Ingelheim's consumer arm has applied to make its urological disorder drug Flomax (tamsulosin) available in the UK from pharmacists …
Over-the-counter Viagra bid ends
November 21, 2008Sales and Marketing ED, OTC, viagra
Plans to make Viagra available through pharmacies in Europe without a prescription have been scuppered by safety concerns.Pfizer has ended …
Latest news from Datamonitor
October 6, 2008Sales and Marketing OTC
Is an Rx-to-OTC move the right prescription to protect pharma revenues and cut healthcare costs? The growing cost of developing …
Pfizer ponders over-the-counter Viagra
January 22, 2007Sales and Marketing OTC
Viagra, the original erectile dysfunction wonder-drug could soon be available from pharmacies across Europe if its manufacturers apply for an …
Omeprazole could be first in wave of blockbuster switches
October 29, 2003OTC
Omeprazole, the blockbuster ulcer drug discovered by AstraZeneca, could soon be dispensed by pharmacists without a prescription, pending final approval …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
